NEW YORK (GenomeWeb News) - Illumina’s stock rose nearly 16 percent, to $70.02, in afternoon trading after this morning’s news that the company will settle its longstanding patent-infringement litigation with Affymetrix without admitting liability and without paying royalties.
 
Under the terms of the settlement, Illumina will pay Affy $90 million and the companies agreed to a covenant not to sue each other in the future.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.